Embitterment symptoms and comorbid psychopathology in an anxiety outpatient clinic: frequency, clinical distribution, and psychosocial correlates.

Chronic rhinosinusitis (CRS) is one of the most common chronic diseases worldwide. It is an upper respiratory tract ailment marked by widespread inflammation of the mucosal lining of the nose and paranasal sinuses. CRS continues to be difficult to control in many situations and it imposes a significant financial burden on society. In addition to causing a significant financial burden, CRS has a major negative impact on the lives of those affected. The effects extend beyond monetary costs; they also include limitations in day-to-day activities, mental stress, and physical discomfort. It may result in a decline in general well-being, social disengagement, and productivity. The etiology of CRS is multifaceted and includes genetic, immunological, infectious, anatomical, and biofilm-related variables. All of these pathophysiological factors inevitably result in chronic inflammation of the sinonasal mucosa (). The prevalence estimates for CRS, according to epidemiological studies conducted worldwide, have been close to 10% when either symptoms or objective findings are considered alone. However, when the diagnostic criteria based on guidelines are followed, which require both symptoms and objective findings, the actual prevalence of CRS is consistently less than 5%. Additionally, it has been shown that nasal polyps are present in approximately one-third of those with a CRS diagnosis (). Two forms of CRS are distinguished: CRS with nasal polyps and CRS without polyps. Facial discomfort and loss of smell are the primary symptoms that distinguish these two types. Both symptoms have a variety of clinical manifestations and are suggestive of a substantial illness effect (). The chronic inflammation and tissue deformation seen in CRS are believed to result from alterations in mucociliary function, defects in the sinonasal epithelial barrier, and ongoing tissue remodeling. Moreover, heightened activity of both the innate and adaptive immune systems appears to play a major role in the pathogenesis of the disease (). In the study of illnesses of the upper respiratory tract, the pathophysiology of vitamin D represents a noteworthy breakthrough. Numerous studies now indicate that vitamin D3 acts as an immunomodulator of both innate and adaptive immunity locally within the respiratory epithelium ().